Biologic Therapeutics Market Size, Share, Trends, Growth Outlook

Biologic Therapeutics Market is estimated to increase at a growth rate of 7.5% CAGR over the forecast period from 2024 to 2030.

The global Biologic Therapeutics Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Vaccines, Blood and Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Proteins, Cellular Therapies, Xenotransplantation Products), By Application (Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics).

An Introduction to Biologic Therapeutics Market in 2024

The Biologic Therapeutics Market focuses on pharmaceuticals, therapeutics, and medicines derived from biological sources, including proteins, antibodies, nucleic acids, and cells, for treating diseases, managing symptoms, and improving patient health. In 2024, biologic therapeutics encompass monoclonal antibodies, recombinant proteins, gene therapies, and cell-based therapies that target specific pathways, molecular targets, and disease mechanisms, offering personalized treatment options and innovative approaches to medical care. With considerations for biopharmaceutical innovations, precision medicine, and therapeutic efficacy, the biologic therapeutics market supports advancements in immunotherapy, oncology treatments, and regenerative therapies across various disease areas.

Biologic Therapeutics Market Competitive Landscape

The global Biologic Therapeutics Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Biologic Therapeutics Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Biologic Therapeutics Industry include- Amgen Inc, Apogenix AG, AstraZeneca Plc, Aurobindo Pharma Ltd, Baxter International Inc, Biocon Ltd, BioMarin Pharmaceutical Inc, Celltrion Healthcare Co. Ltd, Eli Lilly and Co., GangaGen Biotechnologies Pvt Ltd, GlaxoSmithKline Plc, Johnson and Johnson Services Inc, Merck and Co. Inc, Novartis AG, Pfizer Inc.

Biologic Therapeutics Market Trend: Expansion of Targeted Therapies

The expansion of targeted therapies is a prominent trend in the biologic therapeutics market. Targeted therapies, including monoclonal antibodies, recombinant proteins, and gene therapies, offer precise mechanisms of action by selectively targeting specific molecules or pathways involved in disease pathogenesis. This approach enhances therapeutic efficacy, minimizes off-target effects, and improves patient outcomes across various therapeutic areas such as oncology, autoimmune diseases, and rare genetic disorders. The continuous development of innovative biologic drugs with enhanced specificity and therapeutic profiles drives market growth and fosters personalized treatment approaches tailored to individual patient needs.

Biologic Therapeutics Market Driver: Increasing Biopharmaceutical R&D Investment

The increasing investment in biopharmaceutical research and development (R&D) serves as a primary driver for the biologic therapeutics market. Biopharmaceuticals represent a significant portion of drug development pipelines, fueled by advances in biotechnology, genomics, and immunology. Pharmaceutical companies, academic institutions, and government agencies allocate substantial resources towards discovering and developing biologic drugs due to their potential to address unmet medical needs and offer superior therapeutic outcomes compared to conventional small molecule drugs. The growing investment in biologic R&D accelerates drug discovery, clinical translation, and commercialization efforts, driving market expansion and innovation in biologic therapeutics.

Biologic Therapeutics Market Opportunity: Expansion into Emerging Markets

An opportunity for market growth lies in the expansion into emerging markets for biologic therapeutics. Emerging markets exhibit increasing healthcare expenditure, improving infrastructure, and rising demand for advanced biologic drugs to address prevalent diseases such as cancer, diabetes, and cardiovascular disorders. By leveraging strategic partnerships, regulatory harmonization efforts, and market access initiatives, biopharmaceutical companies can capitalize on the growing patient population and unmet medical needs in emerging economies. Tailoring pricing strategies, adapting distribution channels, and investing in local manufacturing capabilities facilitate market penetration and sustain long-term growth in these dynamic regions.

Market Share Analysis: Gene Therapies is the fastest growing segment in the Biologic Therapeutics industry

Gene therapies stand out as the fastest-growing segment within the biologic therapeutics market. These innovative treatments involve the delivery of genetic material into a patient's cells to correct or modify dysfunctional genes, offering potential cures for a wide range of genetic disorders and chronic diseases. The rapid growth of gene therapies can be attributed to several factors. Firstly, advancements in biotechnology and gene editing technologies, such as CRISPR-Cas9, have significantly improved the efficiency and precision of gene delivery, enhancing the therapeutic potential of gene therapies. Additionally, the increasing understanding of the genetic basis of diseases, coupled with the growing availability of genetic testing, has paved the way for the development of targeted gene therapies tailored to individual patients. Moreover, the promising results from clinical trials demonstrating the efficacy of gene therapies in treating conditions like inherited retinal disorders, hemophilia, and certain types of cancer have fueled investor interest and industry investment in this emerging field. With ongoing research and development efforts to expand the scope of gene therapies and address technical and regulatory challenges, this segment is poised for continued rapid growth in the biologic therapeutics market, offering hope for patients with previously untreatable genetic diseases and chronic conditions.

Biologic Therapeutics Market Segmentation

By Product
Vaccines
Blood and Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Proteins
Cellular Therapies
Xenotransplantation Products
By Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
By Source
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Biologic Therapeutics Companies

Amgen Inc
Apogenix AG
AstraZeneca Plc
Aurobindo Pharma Ltd
Baxter International Inc
Biocon Ltd
BioMarin Pharmaceutical Inc
Celltrion Healthcare Co. Ltd
Eli Lilly and Co.
GangaGen Biotechnologies Pvt Ltd
GlaxoSmithKline Plc
Johnson and Johnson Services Inc
Merck and Co. Inc
Novartis AG
Pfizer Inc
* List not Exhaustive

Reasons to Buy the Biologic Therapeutics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Biologic Therapeutics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Biologic Therapeutics Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Biologic Therapeutics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Biologic Therapeutics Market Size Outlook, $ Million, 2021 to 2030
3.2 Biologic Therapeutics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Biologic Therapeutics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Biologic Therapeutics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Biologic Therapeutics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Biologic Therapeutics Industry
4.2 Key Market Trends in Biologic Therapeutics Industry
4.3 Potential Opportunities in Biologic Therapeutics Industry
4.4 Key Challenges in Biologic Therapeutics Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Biologic Therapeutics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Biologic Therapeutics Market Outlook by Segments
7.1 Biologic Therapeutics Market Outlook by Segments, $ Million, 2021- 2030
By Product
Vaccines
Blood and Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Proteins
Cellular Therapies
Xenotransplantation Products
By Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
By Source
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
8 North America Biologic Therapeutics Market Analysis and Outlook To 2030
8.1 Introduction to North America Biologic Therapeutics Markets in 2024
8.2 North America Biologic Therapeutics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Biologic Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Vaccines
Blood and Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Proteins
Cellular Therapies
Xenotransplantation Products
By Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
By Source
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
9 Europe Biologic Therapeutics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Biologic Therapeutics Markets in 2024
9.2 Europe Biologic Therapeutics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Biologic Therapeutics Market Size Outlook by Segments, 2021-2030
By Product
Vaccines
Blood and Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Proteins
Cellular Therapies
Xenotransplantation Products
By Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
By Source
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
10 Asia Pacific Biologic Therapeutics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Biologic Therapeutics Markets in 2024
10.2 Asia Pacific Biologic Therapeutics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Biologic Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Vaccines
Blood and Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Proteins
Cellular Therapies
Xenotransplantation Products
By Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
By Source
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
11 South America Biologic Therapeutics Market Analysis and Outlook To 2030
11.1 Introduction to South America Biologic Therapeutics Markets in 2024
11.2 South America Biologic Therapeutics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Biologic Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Vaccines
Blood and Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Proteins
Cellular Therapies
Xenotransplantation Products
By Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
By Source
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
12 Middle East and Africa Biologic Therapeutics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Biologic Therapeutics Markets in 2024
12.2 Middle East and Africa Biologic Therapeutics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Biologic Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Vaccines
Blood and Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Proteins
Cellular Therapies
Xenotransplantation Products
By Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
By Source
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Amgen Inc
Apogenix AG
AstraZeneca Plc
Aurobindo Pharma Ltd
Baxter International Inc
Biocon Ltd
BioMarin Pharmaceutical Inc
Celltrion Healthcare Co. Ltd
Eli Lilly and Co.
GangaGen Biotechnologies Pvt Ltd
GlaxoSmithKline Plc
Johnson and Johnson Services Inc
Merck and Co. Inc
Novartis AG
Pfizer Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Vaccines
Blood and Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Proteins
Cellular Therapies
Xenotransplantation Products
By Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
By Source
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics